Place de l'antibiotherapie dans la prise en charge des exacerbations de BPCO. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease]

Details

Serval ID
serval:BIB_24FC063746EF
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Place de l'antibiotherapie dans la prise en charge des exacerbations de BPCO. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease]
Journal
Revue Médicale Suisse
Author(s)
Cavassini  M., Calandra  T., Bridevaux  P. O.
ISSN
1660-9379 (Print)
Publication state
Published
Issued date
04/2007
Volume
3
Number
106
Pages
939-42
Notes
English Abstract
Journal Article
Review --- Old month value: Apr 11
Abstract
Two thirds of the exacerbations of chronic obstructive pulmonary disease (COPD) are caused by infections of the respiratory tract. The causative microorganisms differ according to the degree of COPD severity, previous antibiotic therapy and prior bacterial infections. Antibiotics and intensification of bronchodilator therapy are the cornerstones of the management of moderate and severe exacerbations of COPD. Prompt therapy of COPD exacerbations has been shown to reduce the likelihood of hospitalisation and improve the quality of life. In this article, we have reviewed current recommendations regarding the use of antibiotics in the treatment of COPD exacerbations.
Keywords
Anti-Bacterial Agents/*therapeutic use Humans Pulmonary Disease, Chronic Obstructive/*drug therapy/etiology Respiratory Tract Infections/*complications/*drug therapy
Pubmed
Create date
24/01/2008 20:44
Last modification date
20/08/2019 13:03
Usage data